Financial

The company has developed solution for treating speech, language and cognitive disorders with science-based digital brain therapy delivered on mobile devices.

The waterproof device looks like a classical watch, providing discrete support for falls, medication reminders, and a guard against lost-wandering.

The company has developed a next generation prescription decision support at the point of care to help large health systems reduce costs and improve outcomes.

Fourth quarter revenues of $23M represent a Y-o-Y increase of 75%; meanwhile the number of visits increased 67% to 184,000 in the quarter.

The company has developed an artificial intelligence technology that provides initial medical diagnosis from a simple photo and a description of symptoms.

As part of the deal, Gloria will also get an 18-month period of exclusive negotiation with Proteus to establish a joint venture company in China.

The company will use the funds to continue its growth and support further innovation in accurate biometric wearable technology.

The company will use the funds to accelerate production, develop new products, and finance growth initiatives; Eight will start shipping in early spring 2016.

The company is developing a mobile solution for patients with diabetes to better self-manage, and for healthcare providers to expand their reach to patients.

The company will use the funds to increase manufacturing capacity, further develop its Dario Diabetes Management Solution, expand sales and marketing efforts.